Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04707651

Formula Diet Treatment for NASH Patients.

Formula Diet Treatment for Weight Reduction in NASH Patients.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
West German Center of Diabetes and Health · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Non-alcoholic steatohepatitis (NASH) - also called fatty liver - is medically a serious problem because the liver tissue becomes fatty and stiff, and inflammatory reactions occur. This increases the risk of liver fibrosis (= scarring of the liver), liver cirrhosis (= shrunken liver), a liver tumor or death. So far there is no recognized treatment option for this disease. However, there is evidence that a lifestyle change based on a reduced carbohydrate diet, more exercise and a significant weight loss that can improve NASH.

Detailed description

Outpatients with NASH will be included into this lifestyle intervention study. Patients will get nutritional advices and a formula diet for 12 weeks. Clinical visits will take place at baseline, after 4, 12 and after 52 weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFormula dietFormula diet for 12 weeks

Timeline

Start date
2021-01-18
Primary completion
2024-12-31
Completion
2025-03-31
First posted
2021-01-13
Last updated
2024-07-11

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT04707651. Inclusion in this directory is not an endorsement.